Skip to the page

Data / Form D filings / Reactive Biosciences Inc.

Reactive Biosciences Inc.: Form D filings

Reactive Biosciences Inc., a company in Durham, NC, filed 6 Form D notices with the SEC between 2017 and 2023. The latest, on June 22, 2023, reports $4 million sold of a $4 million offering to 10 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
8 DAVIS DRIVE, SUITE 320, Durham, NC, 27709
Phone
(984) 569-4261
Industry
Other
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1700096

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jun 22, 2023New notice$4,000,000$4,000,00010Jun 12, 2023sec.gov
Sep 12, 2022New notice$40,000,000$23,499,998$16,500,00210Aug 5, 2021sec.gov
May 15, 2020Amendment$2,000,000$2,000,00014Dec 20, 2019sec.gov
Jan 3, 2020New notice$2,000,000$2,000,00014Dec 20, 2019sec.gov
Feb 28, 2019New notice$4,250,000$3,000,000$1,250,00014Feb 15, 2019sec.gov
Mar 22, 2017New notice$10,530,292$10,530,29228Mar 1, 2017sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Esther van den BoomExecutive Officer
Peter FarinaDirector
Julie GrantExecutive Officer, Director

Other companies in North Carolina that filed recently

Every Form D from the week of Jun 19, 2023 · All recent filings in North Carolina · All recent Other filings

Read from SEC EDGAR. Amount sold is what Reactive Biosciences Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.